| Line Item | 2025-02-02 | Y/Y |
|---|---|---|
| Revenue | $680.6M | -2.8% |
| Cost of Revenue | $282.8M | -5.5% |
| Gross Profit | $397.8M | -0.8% |
| R&D Expense | $8.4M | +9.1% |
| SG&A Expense | $281.4M | +6.5% |
| Operating Income | $13.6M | -54.6% |
| Pre-tax Income | $16.4M | -48.3% |
| Income Tax | $4.9M | -38.5% |
| Net Income | $11.6M |
| Line Item | 2025-02-02 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.7M | -3.8% |
| Accounts Receivable | $16.8M | +24.6% |
| Current Assets | $246.6M | +15.0% |
| Total Assets | $532.3M | +10.4% |
| Current Liabilities | $155.1M | +45.8% |
| Total Liabilities | $315.9M | +19.3% |
| Stockholders' Equity | $216.4M | -0.5% |
| Line Item | 2025-02-02 | Y/Y |
|---|---|---|
| Operating Cash Flow | $39.0M | -49.0% |
| Capital Expenditures | $21.0M | -26.8% |
| Investing Cash Flow | -$21.5M | +26.3% |
| Financing Cash Flow | -$20.8M | -457.1% |
| Free Cash Flow | $18.0M | -62.4% |
| -51.6% |
| EPS (Basic) | $0.75 | -51.6% |
| EPS (Diluted) | $0.69 | -52.4% |